A 6145 New Jersey General Assembly · 2024-2025 Regular Session

Classifies 7 Hydroxymitragynine as Schedule I drug and bans sale of products containing substance.

This New Jersey bill (A6145) classifies 7-Hydroxymitragynine - a chemical compound found in some kratom products - as a Schedule I controlled substance, meaning it is deemed to have high abuse potential with no accepted medical use. The law directly bans the sale, distribution, or manufacture of any product containing this substance within the state. Manufacturers or distributors must immediately recall products containing 7-Hydroxymitragynine if they suspect such products are being sold. This policy change specifically targets sellers and distributors of products with this chemical, not consumers.
Bill status in committee 1 of 4 stages cleared
Introduction
Dec 2025
Committee Review
Floor Vote
Governor
Introduced Dec 4, 2025 Last action Dec 4, 2025
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
1
Key actions
0
Committee
0
Dec 4, 2025
Introduced
Introduced in the Assembly, Referred to Assembly Consumer Affairs Committee
lower
1 primary · 0 co-sponsors

Sponsors

Role
Legislator
Party
State
District
P
Photo of Sean Kean
Sean Kean
RRepublican
NJ
30